Invetx: Dechra Pharmaceuticals To Acquire Invetx, For Up To $520M

Dechra Pharmaceuticals Limited, a Northwich, Cheshire, UK-based provider of a veterinary pharmaceuticals business, acquired Invetx Inc., a Boston, MA-base company which specializes in protein-based therapeutics for animal health, for up to $520M. The acquisition remains subject to antitrust approval and other customary closing conditions. In addition to the Invetx pipeline, Dechra will gain access to [...]The post Dechra Pharmaceuticals To Acquire Invetx, For Up To $520M appeared first on FinSMEs.